Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
7.77
-0.02 (-0.19%)
At close: Sep 5, 2025, 4:00 PM
7.92
+0.16 (2.00%)
After-hours: Sep 5, 2025, 6:58 PM EDT

Jade Biosciences Statistics

Total Valuation

JBIO has a market cap or net worth of $253.51 million. The enterprise value is $291.72 million.

Market Cap253.51M
Enterprise Value 291.72M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, before market open.

Earnings Date Nov 5, 2025
Ex-Dividend Date n/a

Share Statistics

JBIO has 32.63 million shares outstanding.

Current Share Class 32.63M
Shares Outstanding 32.63M
Shares Change (YoY) n/a
Shares Change (QoQ) +728.11%
Owned by Insiders (%) 1.76%
Owned by Institutions (%) 64.09%
Float 16.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.81

Current Ratio 5.81
Quick Ratio 5.78
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -106.04%
Revenue Per Employee n/a
Profits Per Employee -$3.13M
Employee Count30
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +308.68% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +308.68%
50-Day Moving Average 8.39
200-Day Moving Average 5.17
Relative Strength Index (RSI) 49.69
Average Volume (20 Days) 94,444

Short Selling Information

The latest short interest is 1.90 million, so 5.83% of the outstanding shares have been sold short.

Short Interest 1.90M
Short Previous Month 1.82M
Short % of Shares Out 5.83%
Short % of Float 11.64%
Short Ratio (days to cover) 1.20

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -64.48M
Pretax Income n/a
Net Income -93.96M
EBITDA n/a
EBIT -64.48M
Earnings Per Share (EPS) -$18.79
Full Income Statement

Balance Sheet

The company has $69.39 million in cash and $107.60 million in debt, giving a net cash position of -$38.21 million or -$1.17 per share.

Cash & Cash Equivalents 69.39M
Total Debt 107.60M
Net Cash -38.21M
Net Cash Per Share -$1.17
Equity (Book Value) -46.80M
Book Value Per Share -8.04
Working Capital 57.66M
Full Balance Sheet

Cash Flow

Operating Cash Flow -45.23M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

JBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -37.06%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for JBIO is $16.00, which is 106.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.00
Price Target Difference 106.05%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1